Fred Callori joined the Sermonix Board in November 2021, concurrent with the closing of the company’s series A3 financing round. Mr. Callori currently serves as Senior Vice President of Corporate Development at Xontogeny, a role he has held since September 2017. Fred’s responsibilities at Xontogeny include due diligence, deal structuring and negotiation, company formation, and the operational oversight and management of Xontogeny’s investments. He provides corporate governance, transactional and strategic advice to Xontogeny’s portfolio of companies and serves on several portfolio company boards. In 2018, Fred joined the Perceptive Xontogeny Venture Fund as a Partner to help manage and oversee fund investments in portfolio companies, including continued investments in companies seeded and incubated at Xontogeny.
Prior to joining Xontogeny, Fred was a Partner in the Life Science and Emerging Companies practices of Choate, Hall & Stewart LLP, a Boston law firm ranked among the most active firms worldwide for private equity and venture capital deals. During his 20-year tenure at Choate, Fred developed deep expertise in the formation, structure, financing, and overall corporate development of early-stage and emerging life science companies, including representing leading venture capital and institutional investment firms focused on investing in the sector.
Current role